Cutler Group LP Coherus Bio Sciences, Inc. Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$3.79 - $8.3 $7,580 - $16,600	2,000 New	2,000 $8,000
Q4 2019 Feb 06, 2020	SELL	$16.33 - $21.37 $21,228 - $27,781	-1,300 Reduced 81.25%	300 $5,000
Q3 2019 Oct 28, 2019	SELL	$16.3 - $23.37 $3,260 - $4,674	-200 Reduced 11.11%	1,600 $32,000
Q3 2018 Nov 07, 2018	BUY	$14.45 - $20.25 $24,565 - $34,425	1,700 Added 1700.0%	1,800 $29,000
Q2 2018 Aug 10, 2018	SELL	$10.25 - $17.45 $67,650 - $115,170	-6,600 Reduced 98.51%	100 $1,000
Q1 2018 May 11, 2018	SELL	$9.1 - $13.7 $10,046 - $15,124	-1,104 Reduced 14.15%	6,700 $74,000
Q4 2017 Jan 17, 2018	SELL	$8.35 - $14.4 $64,027 - $110,419	-7,668 Reduced 49.56%	7,804 $68,000
Q3 2017 Oct 17, 2017	BUY	$11.1 - $14.5 $171,739 - $224,344	15,472	15,472 $206,000

130

67.8M

1.68M

91.8K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $83.2M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.